User menu

Lung retention and bioavailability of arsenic after single intratracheal administration of sodium arsenite, sodium arsenate, fly ash and copper smelter dust in the hamster

Bibliographic reference Buchet, Jean-Pierre ; Lauwerys, Robert ; Yager, JW. Lung retention and bioavailability of arsenic after single intratracheal administration of sodium arsenite, sodium arsenate, fly ash and copper smelter dust in the hamster. In: Environmental Geochemistry and Health : official journal of the Society for Environmental Geochemistry and Health, Vol. 17, no. 4, p. 182-188 (1995)
Permanent URL
  1. Axelson, O., Dahlgren, E., Jansson, C.D. and Rehnlund, S.O. 1978. Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter.British Journal of Industrial Medicine,35, 8?15.
  2. Buchet, J.P., Lauwerys, R. and Roels, H. 1980. Comparison of several methods for the determination of arsenic compounds in water and in urine.International Archives of Occupational and Environmental Health,46, 11?29.
  3. Brown, L.M., Pottern, L.M. and Blot, W.J. 1984. Lung cancer in relation to environmental pollutants emitted from industrial sources.Environmental Research,34, 250?261.
  4. EPA 1984.Health assessment document for inorganic arsenic. Final report. Research Triangle Park, NC: US Environmental Protection Agency, Environmental Criteria and Assessment Office, 2-1-3-22, 9-1?9-4 EPA 600/8-83-021F.
  5. Enterline, P.E., Henderson, V.L., and Marsh, G.M. 1987. Exposure to arsenic and respiratory cancer. A reanalysis.American Journal of Epidemiology,125, 929?938.
  6. Hughes, J.P., Polissar, L. and Van Belle, G. 1988. Evaluation and synthesis of health effects studies of communities surrounding arsenic producing industries.International Journal of Epidemiology,17, 407?413.
  7. IARC 1980.Some metals and metallic compounds. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 23 pp. 39?141. Lyon, France. International Agency for Research on Cancer.
  8. Inamasu, T., Hisanaga, A., and Ishinishi, N. 1982. Comparison of arsenic trioxide and calcium arsenate retention in the rat lung after intratracheal instillation.Toxicology Letters,12, 1?5.
  9. Järup, L., and Pershagen, G. 1991. Arsenic exposure, smoking, and lung cancer in smelter workers. A case-control study.American Journal of Epidemiology,134, 545?551.
  10. Kuratsune, M., Tokudane, S., Shirakusa, T., Yoshida, M., Tokumitsu, Y., Hayano, T., and Seita, M. 1974. Occupational lung cancer among copper smelters.International Journal of Cancer,13, 52?558.
  11. Lee, A.M. and Fraumeni, J.F. 1969. Arsenic and respiratory cancer in man: an occupational study.Journal of the National Cancer Institute,42, 1045?1052.
  12. Mabuchi, K., Lilienfeld, A.M. and Snell, L.M. 1979. Lung cancer among pesticide workers exposed to inorganic arsenicals.Archives of Environmental Health,34, 312?320.
  13. Marafante, E. and Vahter, M. 1987. Solubility, retention and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster.Environmental Research,42, 72?82.
  14. Morrow, P.E. 1992. Dust overloading of the lungs: update and appraisal.Toxicology and Applied Pharmacology,113, 1?12.
  15. Muhle, H., Creutzenberg, O., Bellman, B., Heinrich, U. and Mermelstein, R. 1990. Dust overloading of lungs: investigations of various materials, species differences and irreversibility of effects.Journal of Aerosol Medicine,3, Suppl. 1, 111?128.
  16. Ott, M.G., Holder, B.B. and Gordon, H.L. 1974. Respiratory cancer and occupational exposure to arsenicals.Archives of Environmental Health,29, 250?255.
  17. Pershagen, G. 1985. Lung cancer mortality among men living near an arsenic-emitting smelter.American Journal of Epidemiology,122, 684?694.
  18. Pinto, S.S., Henderson, V.L. and Enterline, P.E. 1978. Mortality experience of arsenic-exposed workers.Archives of Environmental Health,33, 325?331.
  19. Tsuda, T., Nagira, T., Yamamoto, M. and Kume, Y. 1990. An epidemiological study on cancer in certified arsenic poisoning patients in Toroku.Industrial Health,28, 53?62.